Prevention of biofilm colonization by gram-negative bacteria on minocycline-rifampin-impregnated catheters sequentially coated with chlorhexidine

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 2, 2014, Pages 1179-1182

  Jamal, Mohamed A ^a   Rosenblatt, Joel S ^a   Hachem, Ray Y ^a   Ying, Jiang ^a   Pravinkumar, Egbert ^a   Nates, Joseph L ^a   Chaftari, Anne Marie P ^a   Raad, Issam I ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE; MINOCYCLINE; RIFAMPICIN; SULFADIAZINE SILVER;

ACINETOBACTER BAUMANNII; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ADHERENCE; BIOFILM; CENTRAL VENOUS CATHETER; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SHELF LIFE; STENOTROPHOMONAS MALTOPHILIA;

ACINETOBACTER BAUMANNII; ANTI-BACTERIAL AGENTS; BIOFILMS; CATHETERS; CHLORHEXIDINE; COLONY COUNT, MICROBIAL; CULTURE MEDIA; DRUG COMBINATIONS; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MINOCYCLINE; PSEUDOMONAS AERUGINOSA; RIFAMPIN; STENOTROPHOMONAS MALTOPHILIA;

EID: 84893464121     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01959-13     Document Type: Article

References (25)

1. Richards MJ, Edwards JR, Culver DH, Gaynes RP. 1999. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit. Care Med. 27:887-892.
2. Pittet D, Tarara D, Wenzel RP. 1994. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 271:1598-1601.
3. Raad I, Hanna H, Maki D. 2007. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect. Dis. 7:645-657. http://dx.doi.org/10.1016/S1473-3099(07)70235-9.
4. Darouiche RO, Berger DH, Khardori N, Robertson CS, Wall MJ, Jr, Metzler MH, Shah S, Mansouri MD, Cerra-Stewart C, Versalovic J, Reardon MJ, Raad II. 2005. Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters: a randomized controlled trial. Ann. Surg. 242:193-200. http://dx.doi.org/10.1097/01.sla.0000171874.29934.61.
5. Mermel LA, Farr BM, Sherertz RJ, Raad II, O'Grady N, Harris JS, Craven DE. 2001. Guidelines for the management of intravascular catheter-related infections. Clin. Infect. Dis. 32:1249-1272. http://dx.doi.org/10.1086/320001.
6. Maki DG, Stolz SM, Wheeler S, Mermel LA. 1997. Prevention of central venous catheter-related bloodstream infection by use of an antisepticimpregnated catheter. A randomized, controlled trial. Ann. Intern. Med. 127:257-266.
7. Raad I. 1998. Intravascular-catheter-related infections. Lancet 351:893-898. http://dx.doi.org/10.1016/S0140-6736(97)10006-X.
8. Hockenhull JC, Dwan KM, Smith GW, Gamble CL, Boland A, Walley TJ, Dickson RC. 2009. The clinical effectiveness of central venous catheters treated with anti-infective agents in preventing catheter-related bloodstream infections: a systematic review. Crit. Care Med. 37:702-712. http://dx.doi.org/10.1097/CCM. 0b013e3181958915.
9. Ramritu P, Halton K, Collignon P, Cook D, Fraenkel D, Battistutta D, Whitby M, Graves N. 2008. A systematic review comparing the relative effectiveness of antimicrobial-coated catheters in intensive care units. Am. J. Infect. Control 36:104-117. http://dx.doi.org/10.1016/j.ajic.2007.02.012.
10. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML, Raad II, Randolph A, Weinstein RA. 2002. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention.MMWRRecommend. Rep. 51(RR-10):1-29. http://www.cdc.gov/mmwr/PDF/rr/rr5110.pdf.
11. Hanna H, Bahna P, Reitzel R, Dvorak T, Chaiban G, Hachem R, Raad I. 2006. Comparative in vitro efficacies and antimicrobial durabilities of novel antimicrobial central venous catheters. Antimicrob. Agents Chemother. 50:3283-3288. http://dx.doi.org/10.1128/AAC.01622-05.
12. Sievert DM, Ricks P, Edwards JR, Schneider A, Patel J, Srinivasan A, Kallen A, Limbago B, Fridkin S. 2013. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect. Control Hosp. Epidemiol. 34:1-14. http://dx.doi.org/10.1086/668770.
13. Gudiol C, Tubau F, Calatayud L, Garcia-Vidal C, Cisnal M, Sanchez-Ortega I, Duarte R, Calvo M, Carratala J. 2011. Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes. J. Antimicrob. Chemother. 66:657-663. http://dx.doi.org/10.1093/jac/ dkq494.
14. Michalopoulos A, Falagas ME, Karatza DC, Alexandropoulou P, Papadakis E, Gregorakos L, Chalevelakis G, Pappas G. 2011. Epidemiologic, clinical characteristics, and risk factors for adverse outcome in multiresistant gram-negative primary bacteremia of critically ill patients. Am. J. Infect. Control 39:396-400. http://dx.doi.org/10.1016/j.ajic.2010.06.017.
15. Raad I, Mohamed JA, Reitzel RA, Jiang Y, Raad S, Al Shuaibi M, Chaftari AM, Hachem RY. 2012. Improved antibiotic-impregnated catheters with extended-spectrum activity against resistant bacteria and fungi. Antimicrob. Agents Chemother. 56:935-941. http://dx.doi.org/10.1128/AAC.05836-11.
16. Raad I, Hanna H, Jiang Y, Dvorak T, Reitzel R, Chaiban G, Sherertz R, Hachem R. 2007. Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob. Agents Chemother. 51:1656-1660. http://dx.doi.org/10.1128/AAC.00350-06.
17. Franklin TJ, Snow GA. 2005. Antimicrobial agents and cell membranes. Springer Science+Business Media LLC, Philadelphia, PA.
18. Darouiche RO, Raad II, Heard SO, Thornby JI, Wenker OC, Gabrielli A, Berg J, Khardori N, Hanna H, Hachem R, Harris RL, Mayhall G. 1999. A comparison of two antimicrobial-impregnated central venous catheters. N. Engl. J. Med. 340:1-8. http://dx.doi.org/10.1056/NEJM199901073400101.
19. Raad I, Reitzel R, Jiang Y, Chemaly RF, Dvorak T, Hachem R. 2008. Anti-adherence activity and antimicrobial durability of anti-infectivecoated catheters against multidrug-resistant bacteria. J. Antimicrob. Chemother. 62:746-750. http://dx.doi.org/10.1093/jac/dkn281.
20. Fraenkel D, Rickard C, Thomas P, Faoagali J, George N, Ware R. 2006. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters. Crit. Care Med. 34:668-675. http://dx.doi.org/10.1097/01.CCM.0000201404.05523.34.
21. Raad I, Darouiche R, Dupuis J, Abi-Said D, Gabrielli A, Hachem R, Wall M, Harris R, Jones J, Buzaid A, Robertson C, Shenaq S, Curling P, Burke T, Ericsson C. 1997. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. Ann. Intern. Med. 127:267-274.
22. Boktour M, Hanna H, Ansari S, Bahna B, Hachem R, Tarrand J, Rolston K, Safdar A, Raad I. 2006. Central venous catheter and Stenotrophomonas maltophilia bacteremia in cancer patients. Cancer 106:1967-1973. http://dx.doi.org/10.1002/ cncr.21846.
23. Crump JA, Collignon PJ. 2000. Intravascular catheter-associated infections. Eur. J. Clin. Microbiol. Infect. Dis. 19:1-8. http://dx.doi.org/10. 1007/s100960050001.
24. Schaberg, D. R., Culver, D. H., Gaynes, R. P. 1991 Major trends in the microbial etiology of nosocomial infection. Am. J. Med. 91:72S-75S. http://dx.doi.org/10.1016/0002-9343(91)90346-Y.
25. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, Fridkin SK. 2008. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect. Control Hosp. Epidemiol. 29:996-1011. http://dx.doi.org/10.1086/591861.